1335 related articles for article (PubMed ID: 15384015)
1. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
2. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
Iseki K; Kinjo K; Iseki C; Takishita S
Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
[TBL] [Abstract][Full Text] [Related]
4. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
[TBL] [Abstract][Full Text] [Related]
6. Predictors of end-stage renal disease and body mass index in a screened cohort.
Iseki K; Ikemiya Y; Fukiyama K
Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
[TBL] [Abstract][Full Text] [Related]
7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
[TBL] [Abstract][Full Text] [Related]
9. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH; Schmid CH; Stark PC; Toto R; Remuzzi G; Ruggenenti P; Marcantoni C; Becker G; Shahinfar S; De Jong PE; De Zeeuw D; Kamper AL; Strangaard S; Levey AS
Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
[TBL] [Abstract][Full Text] [Related]
10. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
Iseki K; Iseki C; Ikemiya Y; Kinjo K; Takishita S
Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
[TBL] [Abstract][Full Text] [Related]
11. Association of uric acid with change in kidney function in healthy normotensive individuals.
Bellomo G; Venanzi S; Verdura C; Saronio P; Esposito A; Timio M
Am J Kidney Dis; 2010 Aug; 56(2):264-72. PubMed ID: 20385436
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure and risk of end-stage renal disease in a screened cohort.
Iseki K; Ikemiya Y; Fukiyama K
Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
[TBL] [Abstract][Full Text] [Related]
14. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
Lin KC; Tsao HM; Chen CH; Chou P
J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia and the metabolic syndrome in Hangzhou.
Cai Z; Xu X; Wu X; Zhou C; Li D
Asia Pac J Clin Nutr; 2009; 18(1):81-7. PubMed ID: 19329400
[TBL] [Abstract][Full Text] [Related]
16. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
17. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
18. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
19. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
Baker JF; Schumacher HR; Krishnan E
Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
